Free Trial
ASX:CT1

Constellation Technologies (CT1) Stock Price, News & Analysis

Constellation Technologies logo

About Constellation Technologies Stock (ASX:CT1)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
983,646 shs
Average Volume
N/A
Market Capitalization
$1.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Constellation Technologies Limited engages in the development and management of Internet of Things (IoT) products for industry and government applications in Australia, the United States, China, and the Middle East. The company provides solutions to cloud, IoT, edge-computing sensors, big data, analytics, machine learning, artificial intelligence, and other advanced technologies. It also offers IoT systems and development, digital twin solutions, IoT hardware development, and digital engineering services. The company was incorporated in 1987 and is based in Melbourne, Australia.

Receive CT1 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Constellation Technologies and its competitors with MarketBeat's FREE daily newsletter.

CT1 Stock News Headlines

From Social Security to Social Prosperity?
In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.
Constellation Technologies Limited
See More Headlines

CT1 Stock Analysis - Frequently Asked Questions

Constellation Technologies Limited (ASX:CT1) posted its earnings results on Thursday, February, 28th. The company reported $0.00 earnings per share for the quarter. Constellation Technologies had a negative net margin of 9.04% and a negative trailing twelve-month return on equity of 13.35%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Constellation Technologies investors own include Neuren Pharmaceuticals (NEU), Macquarie Group (MQG), Magellan Financial Group (MFG), Medlab Clinical (MDC), FBR (FBR), Embark Early Education (EVO) and Dreadnought Resources (DRE).

Company Calendar

Last Earnings
2/28/2019
Today
4/26/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Information Technology Services
Sub-Industry
N/A
Current Symbol
ASX:CT1
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.35 million
Price / Cash Flow
5.63
Book Value
A$0.00 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,470,000,000
Free Float
N/A
Market Cap
$1.47 million
Optionable
Not Optionable
Beta
1.40
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (ASX:CT1) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners